Novel Insights into Chk1 Regulation by Phosphorylation

被引:19
|
作者
Goto, Hidemasa [1 ,2 ]
Kasahara, Kousuke [1 ,3 ]
Inagaki, Masaki [1 ,2 ]
机构
[1] Aichi Canc Ctr Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Nagoya, Aichi 4668550, Japan
[3] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Oncol, Nagoya, Aichi 4678603, Japan
基金
日本学术振兴会;
关键词
Chk1; cell-cycle checkpoint; phosphorylation; CELL-CYCLE CHECKPOINT; DNA-DAMAGE CHECKPOINT; EARLY EMBRYONIC LETHALITY; PREMATURE MITOTIC ENTRY; KINASE; CANCER-THERAPY; REPLICATION STRESS; MEDIATED PHOSPHORYLATION; PROTEIN PHOSPHATASE; HEMATOPOIETIC-CELLS;
D O I
10.1247/csf.14017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Checkpoint kinase 1 (Chk1) is a conserved protein kinase central to the cell-cycle checkpoint during DNA damage response (DDR). Until recently, ATR, a protein kinase activated in response to DNA damage or stalled replication, has been considered as the sole regulator of Chk1. Recent progress, however, has led to the identification of additional protein kinases involved in Chk1 phosphorylation, affecting the subcellular localization and binding partners of Chk1. In fact, spatio-temporal regulation of Chk1 is of critical importance not only in the DDR but also in normal cell-cycle progression. In due course, many potent inhibitors targeted to Chk1 have been developed as anticancer agents and some of these inhibitors are currently in clinical trials. In this review, we summarize the current knowledge of Chk1 regulation by phosphorylation.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 50 条
  • [1] Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
    Parsels, Leslie A.
    Qian, Yushen
    Tanska, Daria M.
    Gross, Marisa
    Zhao, Lili
    Hassan, Maria C.
    Arumugarajah, Sankari
    Parsels, Joshua D.
    Hylander-Gans, Linda
    Simeone, Diane M.
    Morosini, Deborah
    Brown, Jeffrey L.
    Zabludoff, Sonya D.
    Maybaum, Jonathan
    Lawrence, Theodore S.
    Morgan, Meredith A.
    CLINICAL CANCER RESEARCH, 2011, 17 (11) : 3706 - 3715
  • [2] Regulation of Chk1
    Tapia-Alveal, Claudia
    Calonge, Teresa M.
    O'Connell, Matthew J.
    CELL DIVISION, 2009, 4
  • [3] Regulation of Chk1
    Claudia Tapia-Alveal
    Teresa M Calonge
    Matthew J O'Connell
    Cell Division, 4
  • [4] Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation
    Katsuragi, Y
    Sagata, N
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (04) : 1680 - 1689
  • [5] Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation
    Katsuragil, Yoshinori
    Sagata, Norimki
    CELL STRUCTURE AND FUNCTION, 2004, 29 : 80 - 80
  • [6] Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency
    Xu, Naihan
    Libertini, Silvana
    Zhang, Yaou
    Gillespie, David A.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 413 (03) : 465 - 470
  • [7] A novel function of HGF in the activation of Chk1 phosphorylation in colon cancer cells
    Song, Na
    Che, Xiaofang
    Qu, Xiujuan
    Xu, Lu
    Hou, Kezuo
    Liu, Yunpeng
    CANCER RESEARCH, 2017, 77
  • [8] Cytoplasmic occurrence of the Chk1/Cdc25 pathway and regulation of Chk1 in Xenopus oocytes
    Oe, T
    Nakajo, N
    Katsuragi, Y
    Okazaki, K
    Sagata, N
    DEVELOPMENTAL BIOLOGY, 2001, 229 (01) : 250 - 261
  • [9] Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1)
    Shiromizu, T
    Goto, H
    Tomono, Y
    Bartek, J
    Totsukawa, G
    Inoko, A
    Nakanishi, M
    Matsumura, F
    Inagaki, M
    GENES TO CELLS, 2006, 11 (05) : 477 - 485
  • [10] The 1.7 Å crystal structure of human cell cycle checkpoint kinase Chk1:: Implications for Chk1 regulation
    Chen, P
    Luo, C
    Deng, YL
    Ryan, K
    Register, J
    Margosiak, S
    Tempczyk-Russell, A
    Nguyen, B
    Myers, P
    Lundgren, K
    Kan, CC
    O'Connor, PM
    CELL, 2000, 100 (06) : 681 - 692